Format

Send to:

Choose Destination
See comment in PubMed Commons below
N Engl J Med. 2003 Jan 2;348(1):68-72.

Alpha4 integrins as therapeutic targets in autoimmune disease.

Comment on

  • A controlled trial of natalizumab for relapsing multiple sclerosis. [N Engl J Med. 2003]
  • Natalizumab for active Crohn's disease. [N Engl J Med. 2003]
PMID:
12510047
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Write to the Help Desk